"Expediting Access to a Promising New ALS Drug…"

Connecting ALS - A podcast by ALS Association

Categories:

Society & Culture

Welcome to Connecting ALS. This week we dig into the latest development out of Amylyx Pharmaceuticals, which recently announced findings of a phase 2 clinical trial of AMX0035, a drug compound shown to be safe and clinically effective at slowing down disease progression.